PubRank

A Di Iorio

Author PubWeight™ 37.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000 10.19
2 Measuring muscular strength of the lower limbs by hand-held dynamometer: a standard protocol. Aging (Milano) 1999 1.79
3 Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int 2003 1.39
4 Progressive versus catastrophic loss of the ability to walk: implications for the prevention of mobility loss. J Am Geriatr Soc 2001 1.38
5 Duration of amantadine benefit on dyskinesia of severe Parkinson's disease. J Neurol Neurosurg Psychiatry 2004 1.06
6 Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharm Des 2010 1.03
7 Frailty of older age: the role of the endocrine--immune interaction. Curr Pharm Des 2006 1.03
8 Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des 2008 0.98
9 Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol Sci 2002 0.94
10 Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. Eur Rev Med Pharmacol Sci 2012 0.91
11 Correlates of bone quality in older persons. Bone 2006 0.91
12 Frailty in the elderly: the physical dimension. Eura Medicophys 2006 0.90
13 Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1999 0.87
14 Dietary antioxidants as potential pharmacological agents for ischemic stroke. Curr Med Chem 2008 0.86
15 Silent lacunar infarcts in elderly patients with chronic non valvular atrial fibrillation. Aging (Milano) 1996 0.85
16 Switch-over from tolcapone to entacapone in severe Parkinson's disease patients. Eur Neurol 2001 0.84
17 Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms. Neurol Sci 2010 0.81
18 Effect of propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol 1997 0.80
19 Autonomic nervous activity in elderly dipper and non-dipper patients with essential hypertension. Aging (Milano) 1997 0.80
20 Dry eye in allergic conjunctivitis: role of inflammatory infiltrate. Int J Immunopathol Pharmacol 2003 0.80
21 Should female patients undergoing parathyroid-sparing total thyroidectomy receive routine prophylaxis for transient hypocalcemia? Am Surg 2004 0.79
22 Intermittent claudication and risk of cardiovascular events. Angiology 1998 0.78
23 Blood pressure and intellectual function in elderly subjects. Age Ageing 1997 0.78
24 Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects. Biogerontology 2006 0.78
25 Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. J Am Geriatr Soc 2001 0.78
26 Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int J Immunopathol Pharmacol 2003 0.78
27 Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 2009 0.78
28 Headache in children with centrotemporal spikes. Neurophysiol Clin 1999 0.78
29 Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review. Aging Clin Exp Res 2013 0.77
30 [Smoking cessation course organized by the Italian League for the fight against tumors in Milan and Rome: determinants of cessation after the course and after a year]. Epidemiol Prev 2001 0.77
31 Correlation between computed tomography findings of leukoaraiosis and 24-hour blood pressure variability in elderly subjects. J Stroke Cerebrovasc Dis 2007 0.77
32 Molecular approach by PCR is the best method to detect the presence of Chlamydia trachomatis and to define the true agent of ocular bacterial inflammation. Int J Immunopathol Pharmacol 2011 0.76
33 RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b. J Neuroimmunol 2000 0.75
34 [A new therapeutic proposal for intermittent claudication. Propionyl-L-carnitine: new indications concerning mechanism of action]. Minerva Cardioangiol 1998 0.75
35 Blood pressure and dementia: a review. Arch Gerontol Geriatr Suppl 2001 0.75
36 Treatment of hypertension in the elderly. Cardiologia 1999 0.75
37 Preventive health care for older women: life-style recommendations and new directions. Aging (Milano) 2000 0.75
38 [Evaluation of the functional state of the claudication patient]. Minerva Cardioangiol 1999 0.75